论文部分内容阅读
目的探讨建立国境口岸接种不良反应(AEFI)监测体系。方法参照世界卫生组织(WHO)指南。回顾美国和加拿大 AEFI 监测模式,结合国境口岸工作实际,探讨如何建立国境口岸AE-兀监测体系。结果口岸 AEFI 监测体系应采取被动监测模式。与国家食品药品监督管理局的药品不良反应监测体系保持良好的协作机制。同时保持一定独立性;以下几方面是确保监测体系良性运行的关键因素:专业人员和专家队伍、数据信息的收集和分析、充足的资源配置、体系的效率、对外沟通机制、鼓励 AEFI 报告的宽松环境。结论应建立国境口岸统一的 AEFI 监测体系。整合资源。逐步铺开有助于建立口岸统一的 AEFI 监测体系。
Objective To explore the establishment of AEFI monitoring system at border crossings. Methods refer to the World Health Organization (WHO) guidelines. Reviewing the AEFI monitoring model in the United States and Canada and examining how to establish a AE-Wu monitoring system at the border crossings, in combination with the actual work at border crossings. Results Port AEFI monitoring system should adopt passive monitoring mode. And the State Food and Drug Administration adverse drug reaction monitoring system to maintain a good mechanism for collaboration. While maintaining some independence; the following are key elements to ensure the sound performance of the monitoring system: professionals and teams of experts, collection and analysis of data and information, adequate allocation of resources, efficiency of the system, external communication mechanisms, easing of AEFI reporting easing surroundings. Conclusion A unified AEFI monitoring system should be established at the border crossings. Integration of resources. Gradually spread the AEFI monitoring system that helps to establish a unified port.